
Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Morgan Stanley

I'm PortAI, I can summarize articles.
Morgan Stanley analyst maintained a Buy rating on Giant Biogene Holding Co. Ltd. with a price target of HK$78.00. The company's shares closed at HK$39.70. Jefferies also issued a Buy rating, while TR reiterated a Hold rating.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

